Infectious Disease Diagnostics – Products

Nonacus today announced the commercial launch of a new service for Whole Genome Sequencing of SARS-CoV-2, developed to enable the UK government’s Test-To-Release scheme. Assay development for the new service was funded by a grant from Innovate UK, the UK’s innovation agency.

Avacta Group plc, announces that the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain.

Researchers have designed a liquid crystal (LC) based diagnostic kit and a smartphone-based application to enable automatic detection of SARS-CoV-2 ssRNA, which could be used for reliable self-test of SARS-CoV-2 at home without the need for complex equipment or procedures.

Atik Cameras, a designer and manufacturer of advanced scientific imaging solutions, has expanded its collaboration with Original Equipment Manufacturers (OEMs) of real-time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply high-performing cameras for reliable COVID-19 testing.

PerkinElmer, Inc. has announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens.

As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive® 96 SARS-CoV-2 kit.

Preventive measures, accurate disease diagnostics and effective contact tracing are still considered fundamental in efforts to combat the SARS-CoV-2 pandemic. Download this whitepaper to discover serological testing methods, antigen testing methods and the impact of COVID-19 variants and antibody cross reactivity.

AnteoTech’s long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support the accelerated manufacture of its COVID-19 home test.

Avacta’s SARS-CoV-2 rapid antigen test has been developed to identify infectious individuals so that they can isolate promptly and reduce the spread of COVID-19.

Ziath reports how it has worked with the Hubrecht Institute which has developed a pioneering automated test robot, called STRIP-1, capable of processing up to 20,000 samples for SARS-CoV-2 testing in 24 hours.